Cardiovascular Drug Development

Fordyce et al. (Wed,) studied this question.

www.synapsesocial.com/papers/6a004d8323ffc69571e2335a — DOI: https://doi.org/10.1016/j.jacc.2015.03.016

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Outlook for the next 5 years in drug innovation· 2012 · 54 citations
2. Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein· 2009 · 3,658 citations
3. Trends in the globalization of clinical trials· 2007 · 362 citations
4. Cardiovascular Disease in the Developing World and Its Cost-Effective Management· 2005 · 444 citations
5. Improving the FDA's Advisory Committee Process· 2011 · 7 citations